DUBLIN, April 23, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/b57g7v/global_vitamin_d) has announced the addition of the "Global Vitamin D Testing Market 2014-2018" report to their offering.
The analysts forecast the Global Vitamin D Testing Market to grow at a CAGR of 32.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in aging and chronically ill populations worldwide. The Global Vitamin D Testing Market has also been witnessing the increase in product approvals. However, the stringent regulatory requirements could pose a challenge to the growth of this market.
The report, the Global Vitamin D Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Vitamin D Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The Global Vitamin D Testing market is experiencing a significant increase in approvals of the products of the leading vendors. For instance, Qualigen Inc. received the FDA approval for FastPack Vitamin D Immunoassay for use on its proprietary FastPack System for the rapid determination of vitamin D status, and Gold Standard Diagnostics Corp. obtained the FDA clearance for its 25-OH Vitamin D Total ELISA test in July 2013. Moreover, DiaSorin received the FDA clearance for its newly developed LIAISON 25 OH Vitamin D TOTAL assay in February 2012. Thus, these product approvals will have a positive impact on the growth of the market.
According to the report,one of the major drivers is the increase in the aging and chronically ill populations worldwide. Moreover, as a result of the changes in lifestyle and food habits, the majority of the population is prone to several diseases. This increases the demand for various diagnostic procedures, including vitamin D testing. Presently, vitamin D deficiency is associated with several diseases such as cancer, diabetes, heart attack, and depression.
Further, the report states that one of the major challenges is the stringent regulatory approval process for vitamin D testing devices, thus leading to delayed approval of devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Market Segmentation by Category
08. Market Segmentation by Types of Method
09. Market Segmentation by End-users
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
- Abbott Laboratories
- DiaSorin S.p.A.
- Immunodiagnostic Systems Holdings plc
- Roche Holding AG
- Siemens Healthcare Diagnostics Inc.
- DIAsource ImmunoAssays S.A.
- Gold Standard Diagnostics Corp.
- Ortho Clinical Diagnostics Inc.
- Qualigen Inc.
- Quest Diagnostics Inc.
- Tosoh Bioscience Inc.
For more information visit http://www.researchandmarkets.com/research/b57g7v/global_vitamin_d
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets